mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
8e-05 |